Table 4.
Literature review of coronary physiology before versus after treatment of severe aortic stenosis.
| Authors | Citation | N | Baseline | Immediate | p value | Long term | p value | Time | Treatment | Method |
|---|---|---|---|---|---|---|---|---|---|---|
| Resting perfusion (cc/min/g) or Doppler velocity (cm/sec) | ||||||||||
| Nemes et al. [28] | Herz 2002; 27: 780 | 21 | 62.2 | 40.1 | <0.01 | 15 months | SAVR | Echo Doppler (diastolic) | ||
| Hildick-Smith and Shapiro [44] | JACC 2000; 36: 1889 | 27 | 43 | 41 | NS | 6 months | SAVR | Echo Doppler (diastolic) | ||
| Carpeggiani et al. [24] | J CV Med 2008; 9: 893 | 8 | 1.01 | 0.92 | >0.05 | 12 months | SAVR | PET | ||
| Rajappan et al. [70] | Circulation 2003; 107: 3170 | 22 | 1.08 | 1.01 | 0.27 | 12 months | SAVR | PET | ||
| Camuglia et al. [34] | JACC 2014; 63: 1808 | 8 | 22 | 20 | NS | 18 | NS | 12 months | TAVI | Wire (Doppler) |
| Vendrik et al. [35] | JAHA 2020; pending | 13 | 19.98 | 19.7 | NS | 21.44 | 0.397 | 6 months | TAVI | Wire (Doppler) |
| Ahmad et al. [37] | JACC CV Int 2018; 11: 2019 | 30 | 22.13 | 24.84 | 0.1 | TAVI | Wire (Doppler) | |||
| Wiegerinck et al. [36] | Circ CV Int 2015; 8: e002443 | 27 | 24.4 | 25.5 | 0.401 | TAVI | Wire (Doppler) | |||
| Instantaneous wave-free ratio (iFR) | ||||||||||
| Vendrik et al. [35] | JAHA 2020; pending | 13 | 0.82 | 0.83 | NS | 0.83 | 0.735 | 6 months | TAVI | |
| Ahmad et al. [37] | JACC CV Int 2018; 11: 2019 | 30 | 0.88 | 0.88 | 0.94 | TAVI | ||||
| Scarsini et al. [38] | EuroIntervention 2018; 13: 1512 | 145 | 0.89 | 0.89 | 0.66 | TAVI | ||||
| Hyperemic perfusion (cc/min/g) or Doppler velocity (cm/sec) or mean transit time (sec) | ||||||||||
| Nemes et al. [28] | Herz 2002; 27: 780 | 21 | 117 | 91.5 | <0.05 | 15 months | SAVR | Echo Doppler (diastolic) | ||
| Hildick-Smith and Shapiro [44] | JACC 2000; 36: 1889 | 27 | 71 | 108 | <0.01 | 6 months | SAVR | Echo Doppler (diastolic) | ||
| Carpeggiani et al. [24] | J CV Med 2008; 9: 893 | 8 | 1.68 | 1.46 | NS | 12 months | SAVR | PET | ||
| Rajappan et al. [27] | Circulation 2003; 107: 3170 | 22 | 2.17 | 2.27 | 0.61 | 12 months | SAVR | PET | ||
| Camuglia et al. [34] | JACC 2014; 63: 1808 | 8 | 34 | 29 | NS | 39 | NS | 12 months | TAVI | Wire (Doppler) |
| Vendrik et al. [35] | JAHA 2020; pending | 13 | 26.36 | 30.78 | <0.001 | 40.2 | <0.001 | 6 months | TAVI | Wire (Doppler) |
| Wiegerinck et al. [36] | Circ CV Int 2015; 8: e002443 | 27 | 44.5 | 51.1 | 0.027 | TAVI | Wire (Doppler) | |||
| Ahmad et al. [37] | JACC CV Int 2018; 11: 2019 | 30 | 33.44 | 40.33 | 0.004 | TAVI | Wire (Doppler) | |||
| Stoller et al. [48] | EuroIntervention 2018; 14: 166 | 40 | 0.44 | 0.48 | 0.53 | TAVI | Wire (thermo) | |||
| Coronary flow reserve (CFR) | ||||||||||
| Nemes et al. [32] | Herz 2002; 27: 780 | 21 | 1.96 | 2.37 | <0.05 | 15 months | SAVR | Echo Doppler (diastolic) | ||
| Hildick-Smith and Shapiro [44] | JACC 2000; 36: 1889 | 27 | 1.76 | 2.61 | <0.01 | 6 months | SAVR | Echo Doppler (diastolic) | ||
| Carpeggiani et al. [24] | J CV Med 2008; 9: 893 | 8 | 1.68 | 1.58 | NS | 12 months | SAVR | PET | ||
| Rajappan et al. [70] | Circulation 2003; 107: 3170 | 22 | 2.02 | 2.28 | 0.17 | 12 months | SAVR | PET | ||
| Camuglia et al. [34] | JACC 2014; 63: 1808 | 8 | 1.53 | 1.58 | 0.41 | 2.18 | <0.01 | 12 months | TAVI | Wire (Doppler) |
| Vendrik et al. [35] | JAHA 2020; pending | 13 | 1.28 | 1.65 | <0.001 | 1.94 | <0.001 | 6 months | TAVI | Wire (Doppler) |
| Wiegerinck et al. [36] | Circ CV Int 2015; 8: e002443 | 27 | 1.9 | 2.1 | 0.113 | TAVI | Wire (Doppler) | |||
| Stoller et al. [48] | EuroIntervention 2018; 14: 166 | 40 | 1.9 | 2 | 0.72 | TAVI | Wire (thermo) | |||
| Fractional flow reserve (FFR) | ||||||||||
| Stundl et al. [41] | Clin Res Cardiol 2019; Epub | 13 | 0.77 | 0.76 | 0.11 | 2 months | TAVI | |||
| Vendrik et al. [35] | JAHA 2020; pending | 13 | 0.85 | 0.79 | <0.001 | 0.71 | <0.001 | 6 months | TAVI | |
| Ahmad et al. [37] | JACC CV Int 2018; 11: 2019 | 30 | 0.87 | 0.85 | 0.0008 | TAVI | ||||
| Stoller et al. [48] | EuroIntervention 2018; 14: 166 | 40 | 0.9 | 0.93 | 0.0021 | TAVI | ||||
| Pesarini et al. [71] | Circ CV Int 2016; 9: e004088 | 133 | 0.89 | 0.89 | 0.73 | TAVI | ||||
NS = not significant (actual p value not reported), PET = positron emission tomography, SAVR = surgical aortic valve replacement, TAVI = transcatheter aortic valve implantation, and thermo = bolus thermodilution (based on the table from 2020 editorial [68]).